In response to the FDA guidance document for Babesia, CTS will implement the licensed Grifols Babesia test for samples received on April 20, 2020 at the Charlotte, Dallas, Phoenix, St. Louis and Tampa laboratories. Be watching for details on an upcoming webinar that will provide you with an overview of implementing this testing.
Check out the Communication page for the complete details by clicking the link: Communications
As communicated on January 21, 2020, CTS will implement the licensed Grifols Babesia test for sample...
CTS lab staff recently participated in a Kaizen and determined emailed Daily Shipment Schedules to b...
CTS Tampa has implemented the Ortho Vitros Anti-SARS-CoV-2 Total test which qualitatively detects an...
As winter weather continues to move through parts of the US, we would like to remind you it may be n...
FDA Guidance titled “Further Testing of Donations that are Reactive on a Licensed Donor Screen...
The recent communication regarding the recent Anti-SARS-CoV-2 Total assay in Tampa has brought about...